Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its late-stage candidate for metabolic dysfunction-associated steatohepatitis (MASH). The $14.50-per-share deal ...
The Liberal National Party Attorney-General, Deb Frecklington, said the changes would put “trade unions, property developers and anyone else who wants to donate on a level playing field”. The LNP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback